Grand Brilliance Group Holdings Ltd is an investment holding company primarily engaged in the supply of medical devices. The Company also provides medical device solutions, including market trend analysis, medical device procurement, after-sales service, technical support and training, medical device rental services, and quality assurance. The Company primarily sells medical device products, including medical consumables, medical equipment, and medical devices. In addition, the Company also offers repair services and medical device rental services.

Employees

Sector

Medical Equipment, Supplies & Distribution

More about the company

Quotes

Date	Price	Change	Volume
10/11/26	HK$0.1590	0.00%	0
09/11/26	HK$0.1590	0.00%	50,000
06/11/26	HK$0.1590	0.00%	0
05/11/26	HK$0.1590	-0.63%	290,000
04/11/26	HK$0.1600	0.00%	40,000

Delayed Quote Hong Kong S.E.

More quotes

Market Closed - Hong Kong S.E. 11:08:36 10/11/2026 +03			5-day change	1st Jan Change
0.1590 ^HKD	0.00%		-4.22%	+21.37%

10-23	Grand Brilliance Group Holdings Limited Provides Unaudited Consolidated Earnings Guidance for Six Months Ended 30 September 2026	CI
06-26	Grand Brilliance Group Holdings Limited Announces Interim Ordinary Cash Dividend for the Financial Year End 31 March 2026, Payable on August 10, 2026	CI

Market Cap	127M 16.21M 14.54M 13.4M 12.17M 23.03M 1.52B 23.69M 160M 63.93M 814M 60.85M 59.55M 2.57B	P/E 2025	9.13x	P/E 2026	12.5x
Enterprise Value	71.85M 9.16M 8.21M 7.57M 6.87M 13.01M 859M 13.38M 90.63M 36.11M 460M 34.37M 33.64M 1.45B	EV / Sales 2025	0.25x	EV / Sales 2026	0.49x
Free-Float	26.9%	Yield 2025	2.31%	Yield 2026	1.91%

10-23	Grand Brilliance Group Holdings Limited Provides Unaudited Consolidated Earnings Guidance for Six Months Ended 30 September 2026	CI
06-26	Grand Brilliance Group Holdings Limited Announces Interim Ordinary Cash Dividend for the Financial Year End 31 March 2026, Payable on August 10, 2026	CI
06-26	Grand Brilliance Group Holdings Limited Reports Earnings Results for the Full Year Ended March 31, 2026	CI
11-21	Grand Brilliance Group Holdings Limited Reports Earnings Results for the Half Year Ended September 30, 2025	CI
20/06/25	Grand Brilliance Group Holdings Limited Reports Earnings Results for the Full Year Ended March 31, 2025	CI
20/06/25	Grand Brilliance Group Holdings Limited Announces Interim Dividend for the Financial Year End 31 March 2025, Payable on August 11, 2025	CI
27/05/25	Grand Brilliance Group Holdings Limited Announces Board and Committee Changes, Effective 1 June 2025	CI
14/03/25	Grand Brilliance Group Holdings Limited Announces Resignation of Mr. Mui Wai Sum as Independent Non-Executive Director and Chairman and Member of the Audit Committee and Member of Remuneration Committee	CI
08/11/24	Grand Brilliance Group Holdings Limited Reports Earnings Results for the Half Year Ended September 30, 2024	CI
28/06/24	Grand Brilliance Group Holdings Limited Declares Interim Dividend for the Year Ended 31 March 2024, Payable on or Before 12 August 2024	CI
28/06/24	Grand Brilliance Group Holdings Limited Reports Earnings Results for the Full Year Ended March 31, 2024	CI
13/11/23	Grand Brilliance Group Holdings Limited Reports Earnings Results for the Half Year Ended September 30, 2023	CI
15/09/23	Grand Brilliance Group Holdings Limited Announces Board Changes, Effective September 18, 2023	CI

1 week	-4.22%
Current month	-4.22%
1 month	-5.92%
3 months	+25.20%
6 months	+11.97%
Current year	+21.37%

Grand Brilliance Group Holdings Limited Stock

Stocks

8372

KYG4136R1020

Medical Equipment, Supplies & Distribution

Valuation: Grand Brilliance Group Holdings Limited

Chart: Grand Brilliance Group Holdings Limited

Latest news: Grand Brilliance Group Holdings Limited

Quotes and Performance

Price Extremes

Managers and Directors: Grand Brilliance Group Holdings Limited

Medical Equipment Wholesale

Financials

Company Profile

Quotes

1 week	0.16	0.16
1 month	0.15	0.17
Current year	0.12	0.18
1 year	0.1	0.18
3 years	0.08	0.18
5 years	0.06	0.18
10 years	0.06	0.57

Manager	Title	Age	Since
Bik Kwan Wong CEO	Chief Executive Officer	57	01/03/2018
Chong Chi Cheung DFI	Director of Finance/CFO	48	-
Wai Man Lau SAM	Sales & Marketing	39	01/02/2015

Director	Title	Age	Since
Bik Kwan Wong CHM	Chairman	57	01/03/2018
Yin Shun Miu BRD	Director/Board Member	59	18/09/2017
Man Wai Chiu BRD	Director/Board Member	57	18/09/2017

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
GRAND BRILLIANCE GROUP HOLDINGS LIMITED	0.00%	-4.22%	+43.24%	+72.83%	16.22M
ABBOTT LABORATORIES	-0.52%	+0.60%	-12.57%	+17.12%	191B
MEDTRONIC PLC	-1.24%	+2.73%	+9.62%	+43.71%	126B
STRYKER CORPORATION	-1.03%	+3.81%	-9.19%	+17.82%	124B
ESSILORLUXOTTICA	-1.57%	+1.82%	-39.83%	+7.26%	98.14B
CENCORA, INC.	+0.29%	+1.82%	-4.92%	+75.49%	65.98B
BECTON, DICKINSON AND COMPANY	-0.53%	+7.79%	+17.60%	-8.97%	58.63B
IDEXX LABORATORIES, INC.	-1.54%	+3.53%	-1.95%	+62.28%	55.67B
HOYA CORPORATION	+1.42%	-5.09%	-7.57%	+50.74%	48.78B
ALCON INC.	+1.08%	+3.41%	+4.00%	-4.71%	36.03B
Average	-0.36%	+1.71%	-0.16%	+33.36%	80B
Weighted average by Cap.	-0.65%	+2.53%	-7.30%	+27.26%

	2025	2026
Net sales	94.45M 12.04M 10.8M 9.95M 9.04M 17.1M 1.13B 17.59M 119M 47.47M 605M 45.18M 44.22M 1.91B	101M 12.84M 11.51M 10.61M 9.64M 18.24M 1.2B 18.75M 127M 50.62M 645M 48.18M 47.15M 2.04B
Net income	9.46M 1.21M 1.08M 997K 905K 1.71M 113M 1.76M 11.93M 4.75M 60.57M 4.53M 4.43M 191M	8.41M 1.07M 962K 886K 805K 1.52M 101M 1.57M 10.61M 4.23M 53.87M 4.02M 3.94M 170M
Net Debt	-62.36M -7.95M -7.13M -6.57M -5.97M -11.29M -745M -11.61M -78.67M -31.34M -399M -29.83M -29.2M -1.26B	-55.35M -7.06M -6.33M -5.83M -5.3M -10.02M -662M -10.31M -69.82M -27.82M -354M -26.48M -25.91M -1.12B